List of Agendia patents | 6 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8969000 Prognostic gene expression signature for non small cell lung cancer patients	Patent 8969000 was granted and assigned to Agendia on March, 2015 by the United States Patent and Trademark Office.		Agendia	United States Patent and Trademark Office	8969000	March 3, 2015
‌ US Patent 10036070 Methods and means for molecular classification of colorectal cancers	Patent 10036070 was granted and assigned to Agendia on July, 2018 by the United States Patent and Trademark Office.		Agendia	United States Patent and Trademark Office	10036070	July 31, 2018
‌ US Patent 9175351 Means and methods for molecular classification of breast cancer	Patent 9175351 was granted and assigned to Agendia on November, 2015 by the United States Patent and Trademark Office.		Agendia	United States Patent and Trademark Office	9175351	November 3, 2015
‌ US Patent 8658371 Means and method for determining tumor cell percentage in a sample	Patent 8658371 was granted and assigned to Agendia on February, 2014 by the United States Patent and Trademark Office.		Agendia	United States Patent and Trademark Office	8658371	February 25, 2014
‌ US Patent 8921051 Methods and means for typing a sample comprising colorectal cancer cells	Patent 8921051 was granted and assigned to Agendia on December, 2014 by the United States Patent and Trademark Office.		Agendia	United States Patent and Trademark Office	8921051	December 30, 2014
‌ US Patent 10072301 Means and methods for molecular classification of breast cancer	Patent 10072301 was granted and assigned to Agendia on September, 2018 by the United States Patent and Trademark Office.	Agendia	Agendia	United States Patent and Trademark Office	10072301	September 11, 2018